MFDS
- Marketing authorisation holder: LILLY
- Status: likely_approved
🇰🇷 Metholone in South Korea
Metholone (drostanolone propionate) regulatory status in South Korea.
Marketing authorisation
Metholone in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Metholone approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Metholone in South Korea?
LILLY holds the South Korean marketing authorisation.